Cognito Therapeutics Appoints Greg Weaver as Chief Financial Officer
October 17, 2023 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics, a pioneer developing disease-modifying therapeutics to treat CNS diseases, today announced the appointment of Greg Weaver as Chief Financial Officer (CFO), to lead all finance-related and investor relations functions at the Company. “I am excited to join Cognito at such a dynamic time. The company is advancing its pivotal HOPE study in Alzheimer’s … Continue reading Cognito Therapeutics Appoints Greg Weaver as Chief Financial Officer